130. Sullender, R. T., et al. (2023, November 20). Perception and comfort with endometriosis management among OB/GYN residents. International Journal of Women’s Health, 2023(15), 1801–1809. https://pubmed.ncbi.nlm.nih.gov/38020939/ 131. Vesco, K. K., et al. (2024, Feb 1). Resident training to optimize patient-focused menopause management: A multispecialty menopause curriculum to enhance knowledge and preparedness. Menopause, 31(2), 93–100. https://pubmed.ncbi.nlm.nih.gov/38166240/ 132. Horne, A. W., & Missmer, S. A. (2022, November 14). Pathophysiology, diagnosis, and management of endometriosis. BMJ, 379, e070750. https://pubmed.ncbi.nlm.nih.gov/36375827/ 133. Singer, M. R., et al. (2020, March 11). Pediatricians’ knowledge, attitudes, and practices surrounding menstruation and feminine products. International Journal of Adolescent Medicine and Health. https://www.degruyter.com/document/ doi/10.1515/ijamh-2019-0179/html 134. Topcu, E. G., et al. (2023, February). Postgraduate training in pediatric and adolescent gynecology: Trainees’ perspectives. Journal of Pediatric and Adolescent Gynecology, 36(1), 18–24. https://www.sciencedirect.com/science/ article/abs/pii/S1083318822002224 135. Lind, M., et al. (2020, April 1). Worldwide secular trends in age at pubertal onset assessed by breast development among girls: A systematic review and meta-analysis. JAMA Pediatrics, 174(4). https://pubmed.ncbi.nlm.nih.gov/32040143/ 136. Sørensen, K., et al. (2012, April 12). Recent secular trends in pubertal timing: Implications for evaluation and diagnosis of precocious puberty. Hormone Research in Paediatrics, 77(3), 137–145. https://doi.org/10.1159/000336325 137. World Economic Forum & McKinsey Health Institute. (2024). Analysis of Phase 3 and resulting trials for each condition, reviewing hazard ratio, overall survival and progression-free survival against the gender or race disparity. 138. Jemal, A., et al. (2017, October 16). Factors that contributed to Black–white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. Journal of Clinical Oncology, 36(1). https://ascopubs.org/doi/ full/10.1200/JCO.2017.73.7932 139. Spencer, J. C., et al. (2023, October). Racial and ethnic disparities in cervical cancer screening from three U.S. healthcare settings. American Journal of Preventive Medicine, 65(4), 667–677. https://www.ajpmonline.org/article/S0749- 3797(23)00202-7/fulltext 140. Boitano, T. K. L., et al. (2022, August). Increased disparities associated with Black women and abnormal cervical cancer screening follow-up. Gynecologic Oncology Reports, 42, 101041. https://doi.org/10.1016/j.gore.2022.101041 141. Tjokroprawiro, B. A., et al. (2024, February). The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia. Gynecologic Oncology Reports, 51, 101325. https://www.sciencedirect.com/ science/article/pii/S2352578924000043 142. Suman, S., Pravalika, J., Manjula, P ., & Farooq, U. (2023, May). Gender and CVD: Does it really matter? Current Problems in Cardiology, 48(5), 101604. https://pubmed.ncbi.nlm.nih.gov/36690310/ 143. Phase 3 clinical trials compare the effectiveness and safety of a medication against other treatments; trials may compare which groups have higher survival rates or fewer side effects. Minissian, M. B., et al. (2022, September). Ischaemic heart disease in young women: JACC review topic of the week. Journal of the American College of Cardiology, 80(10), 1014–1022. https://doi.org/10.1016/j.jacc.2022.01.057 144. Sawano, M., et al. (2023). Sex difference in outcomes of acute myocardial infarction in young patients. Journal of the American College of Cardiology, 81(18), 1797–1806. https://pubmed.ncbi.nlm.nih.gov/37137590/ 145. The Lancet. (2023, October). Navigating disparities in cardiovascular disease outcomes across Europe: a call to action. The Lancet, 33, 100746. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00165-5/fulltext 146. Romeo, B., et al. (2024, September 2025). Sex disparities in ischaemic heart disease mortality in Europe. JACC: Advances. https://www.jacc.org/doi/abs/10.1016/j.jacadv.2024.101252 147. Kiran, G., et al. (2020, July 17). Escalating ischaemic heart disease burden among women in India: Insights from GBD, NCDRisC and NFHS reports. American Journal of Preventive Cardiology, 2, 100035. https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC8315408/#bib38https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00165-5/fulltext 148. Commonwealth Fund. (2024, June 4). Insights into the U.S. maternal mortality crisis: An international comparison. https://www.commonwealthfund.org/publications/issue-briefs/2024/jun/insights-us-maternal-mortality-crisis- international-comparison 149. World Health Organization. (2024, April 26). Maternal mortality. https://www.who.int/news-room/fact-sheets/detail/ maternal-mortality. 150. Callaghan, W. M., Kuklina, E. V., & Berg, C. J. (2010, April). Trends in postpartum haemorrhage: United States, 1994– 2006. American Journal of Obstetrics and Gynecology, 202(4), 353.e1–6. https://pubmed.ncbi.nlm.nih.gov/20350642/ 151. Guan, C. S., et al. (2023). Racial disparities in care escalation for postpartum haemorrhage requiring transfusion. American Journal of Obstetrics & Gynecology MFM, 5(6), 100938. https://www.sciencedirect.com/science/article/abs/pii/ S2589933323000800 152. Commonwealth Fund. (2024, June 4). Insights into the U.S. maternal mortality crisis: An international comparison. https://www.commonwealthfund.org/publications/issue-briefs/2024/jun/insights-us-maternal-mortality-crisis- international-comparison Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All 58

Blueprint to Close the Women%E2%80%99s Health Gap 2025